The Evolving Role of C-Reactive Protein in Heart Failure Implications for Patients With Cardiovascular Disease

被引：3
作者：
Jialal, Ishwarlal [1 ,3 ]
Ebong, Imo A. [2 ]
机构：
[1] Univ Calif Davis, Dept Pathol & Internal Med, Sacramento, CA USA
[2] Univ Calif Davis, Div Cardiovasc Med, Sacramento, CA USA
[3] UC Davis Sch Med, Pathol Med, 4635 Second Ave, Sacramento, CA 95817 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 82卷 / 05期
关键词：
cardiovascular disease; CRP; ejection fraction; heart failure; inflammation; RISK; INFLAMMATION; DYSFUNCTION;
D O I：
10.1016/j.jacc.2023.05.036
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：427 / 429
页数：3
相关论文
共 16 条
  • [1] Reappraising the role of inflammation in heart failure
    Adamo, Luigi
    Rocha-Resende, Cibele
    Prabhu, Sumanth D.
    Mann, Douglas L.
    [J]. NATURE REVIEWS CARDIOLOGY, 2020, 17 (05) : 269 - 285
  • [2] A systematic review examining the effects of sodium-glucose cotransporter-2 inhibitors (SGLT2is) on biomarkers of inflammation and oxidative stress
    Bray, Jonathan J. H.
    Foster-Davies, Harri
    Stephens, Jeffrey W.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 168
  • [3] C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease
    Burger, Pascal M.
    Koudstaal, Stefan
    Mosterd, Arend
    Fiolet, Aernoud T. L.
    Teraa, Martin
    van der Meer, Manon G.
    Cramer, Maarten J.
    Visseren, Frank L. J.
    Ridker, Paul M.
    Dorresteijn, Jannick A. N.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (05) : 414 - 426
  • [4] Mid- to Late-Life Inflammation and Risk of Cardiac Dysfunction, HFpEF and HFrEF in Late Life
    Cohen, Aaron J.
    Teramoto, Kanako
    Claggett, Brian
    Buckley, Leo
    Solomon, Scott
    Ballantyne, Christie
    Selvin, Elizabeth
    Shah, Amil M.
    [J]. JOURNAL OF CARDIAC FAILURE, 2021, 27 (12) : 1382 - 1392
  • [5] The Evolving Role of C-Reactive Protein in Atherothrombosis
    Devaraj, Sridevi
    Singh, Uma
    Jialal, Ishwarlal
    [J]. CLINICAL CHEMISTRY, 2009, 55 (02) : 229 - 238
  • [6] High-sensitivity C-reactive protein in heart failure with preserved ejection fraction
    DuBrock, Hilary M.
    AbouEzzeddine, Omar F.
    Redfield, Margaret M.
    [J]. PLOS ONE, 2018, 13 (08):
  • [7] Cardiac Biomarkers in Advanced Heart Failure: How Can They Impact Our Pre-transplant or Pre-LVAD Decision-making
    Ebong, Imo
    Mazimba, Sula
    Breathett, Khadijah
    [J]. CURRENT HEART FAILURE REPORTS, 2019, 16 (06) : 274 - 284
  • [8] Mechanisms of heart failure in obesity
    Ebong, Imo A.
    Goff, David C., Jr.
    Rodriguez, Carlos J.
    Chen, Haiying
    Bertoni, Alain G.
    [J]. OBESITY RESEARCH & CLINICAL PRACTICE, 2014, 8 (06) : E540 - E548
  • [9] Cardiovascular protection by SGLT2 inhibitors-Do anti-inflammatory mechanisms play a role?
    Elrakaybi, Asmaa
    Laubner, Katharina
    Zhou, Qian
    Hug, Martin J.
    Seufert, Jochen
    [J]. MOLECULAR METABOLISM, 2022, 64
  • [10] Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023
    ElSayed, Nuha A.
    Aleppo, Grazia
    Aroda, Vanita R.
    Bannuru, Raveendhara R.
    Brown, Florence M.
    Bruemmer, Dennis
    Collins, Billy S.
    Das, Sandeep R.
    Hilliard, Marisa E.
    Isaacs, Diana
    Johnson, Eric L.
    Kahan, Scott
    Khunti, Kamlesh
    Kosiborod, Mikhail
    Leon, Jose
    Lyons, Sarah K.
    Perry, Mary Lou
    Prahalad, Priya
    Pratley, Richard E.
    Seley, Jane Jeffrie
    Stanton, Robert C.
    Gabbay, Robert A.
    [J]. DIABETES CARE, 2023, 46 : S158 - S190
12